|
Hematologic Malignancy Grand Rounds - FY18 Mantle Cell Lymphoma: Prognostic Markers and Approaches to the Elderly |
10/27/2017 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Leveraging MRD in DLBCL After CAR Therapy |
10/20/2017 - 9:00am to 10:15am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Improving Outcomes in Myeloid Malignancies Using Hematopoietic Cell Transplantation |
09/29/2017 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Immunotherapy in EBV Lymphoproliferative Disorders A Case Presentation |
06/01/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Immunotherapies for T Cell Lymphoma: Targeting the T Cell Receptor |
12/01/2017 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 Genomic diagnosis and treatment of lymphomas: From single cells to many humans |
03/09/2018 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 Generation Next in CLL Therapeutics |
06/29/2018 - 9:00am to 10:00am EDT |
|
Hematologic Malignancy Grand Rounds - FY18 Discovering Targeted Approaches to Poor-Risk Acute Myeloid Leukemia |
12/15/2017 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 Discovering Targeted Approaches to Poor-Risk Acute Myeloid Leukemia |
12/08/2017 - 9:00am to 10:00am EST |
|
Hematologic Malignancy Grand Rounds - FY18 Directions in the Treatment of Marginal Zone Lymphoma |
08/18/2017 - 9:00am to 10:00am EDT |
Facebook
X
LinkedIn
Forward